IL6 and malignant colon neoplasm: Furthermore, we demonstrated that LPEs behave as anti-inflammatory agents able to prevent or counteract the invasiveness of colon cancer cells, mainly by the inhibition of IL-6-dependent effects induced on MMP-2 activity and expression.